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Abstract
The modern demand for effective treatment options in dermatology was successfully 
addressed by the invention of cryogenic method. By 2009, Dr. V.I. Kochenov had devel­
oped and patented cryogenic set of instruments based on 30 years of his personal clinical 
experience. The set includes a number of instruments, which could be used indepen­
dently. It allows implementing a wide range of therapeutic and surgical procedures 
and has no commercially available alternatives. The main applications of the set include 
cryogenic revitalization, and treatment for such common dermatological ailments as pso­
riasis, warts, acne, hypertrophic scars, purulent diseases of the skin and subcutaneous 
fat, epithelial cysts, skin hemangiomas, precancerous skin lesions, and even malignant 
melanoma of the skin. A brief overview of etiology, classification and pathogenesis of 
these maladies is presented alongside with the step-by-step guidelines to cryo-exposure 
procedures. Not only guidelines but also comprehensive theoretical and practical train­
ing is provided to physicians at the center which was established at Nizhny Novgorod 
State Medical Academy. Physicians at Scientific Clinical Center of Medical Cryology 
“OnKolor” have been using the set, which proved to be effective even in the most dif­
ficult and otherwise costly cases. The procedures that have pronounced cosmetic effect, 
leaves no scars and dark spots.
Keywords: cryosurgery, cryotherapy, premalignancy, melanoma, acne, hemangioma, 
treatment dermatologic diseases
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1. Introduction
Today, cryogenic treatment method is worth being applied much more widely than it occurs 
in reality. Paradoxically, cryosurgery has its opponents, despite the fact that this method has 
almost no complications, and its high efficiency in many situations based deeply in physiol­
ogy and immunology puts it above traditional treatment methods. Cryodestruction differs 
favorably from all known methods of active treatment by properties such as, for example, 
complete ablasticity in the treatment of malignant tumors, natural immunostimulating effects, 
and organotypic regeneration.
The main objective of the cryosurgical method can be defined as the absolute destruction of 
pathological cells in a given volume of living tissue without damaging the normal, healthy 
cells around this tissue.
The effectiveness of cryosurgery has been demonstrated primarily in such areas of medicine as 
dermatology. In 1938, the first in-depth clinical study was published—a book by M.A. Beridze 
“About the use of cryotherapy in dermatology,” where the method was described imagina­
tively and in detail and the long-term treatment outcomes were presented. The author noticed 
that the removal of skin neoplasms with dry ice does not leave scars, and made recommenda­
tions on the proper use of cryotherapy.
Cryosurgery studies were carried out in almost all areas of medicine. Among these new 
technological developments in medical cryology, the most notable are cryogenic treatment 
methods patented by Scientific Clinical Center of Medical Cryology “OnKolor,” which have 
a very diverse range of medical applications. In Nizhny Novgorod State Medical Academy 
(Rector—Prof. B.E. Shakhov) and Scientific Research Institute of Applied and Fundamental 
Medicine (Director—Prof. S.N. Tsybusov), cryogenic methods of treatment are applied in oto­
rhinolaryngology, gynecology, dermatology, oncology, and proctology (implemented by the 
medical team under the leadership of Prof. S.N. Tsybusov and Dr. V.I. Kochenov).
A “Set of instruments for medical cryology by Dr. V.I. Kochenov” was developed and approved 
by the Ministry of Health of the Russian Federation in 2009. This invention allows imple­
menting all the available and a number of new treatment technologies in medical cryology in 
any area of clinical medicine. A center for theoretical and practical training was established 
at Federal State Budgetary Educational Institution of Higher Education “Nizhny Novgorod 
State Medical Academy,” Ministry of Health of the Russian Federation, where physicians of 
any clinical specialty relevant to medical cryology can take comprehensive training including 
new patented technologies using this set of instruments.
The set of instruments for medical cryology was developed upon 30 years personal experience 
of Dr. V.I. Kochenov, holder of second-level doctorate degree in Medical Sciences, certified 
physician of highest category, Co-chairman of All-Russian cryosurgical society, ISC member, 
inventor, and Director of Scientific Center of Medical Cryology “OnKolor.” All components 
of the set passed long-term clinical testing. This set of instruments for medical cryology is 
unique (never manufactured previously), all cryo-instruments have the original design and 
each is protected by the RF patent. Its composition is ample for diverse applications in medi­
cal cryology: cosmetology, dermatology, otolaryngology, stomatology, surgery, proctology, 
gynecology, oncology and other areas of clinical medicine.
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Patented cryo-exposure techniques are based on the phenomenon of liquefaction of the ambi­
ent oxygen fraction, which creates the effects of cryo-oxygen saturation, cryo-oxygenation in 
pathologically altered tissues, as well as cryo-oxy-cavitation and cryo-ozone destruction of 
neoplasms, and have contributed significantly to the treatment of visually localized tumors.
The set includes: cryoclamps of various modifications—their design allows for the radical 
elimination of pathologically altered tissues; a cryospray unit with various nozzles; ring-
shaped cryoapplicators with different ring opening and a tube; ring-shaped magnets with 
an opening; cryotrocar; Dr. V.I. Kochenov’s cryogenic device “Ledok” (Icelet) with cannulas 
of different diameters; tampons for deep cryogenic massage with a meshed-cellular elastic 
surface and inserted thermal accumulators; a roller placed on the handle for cryosurgical 
massage; cryosticks with different configurations of the working surface; and a device for 
columnar cryobiopsy of the frozen tissue.
These instruments were developed for the purposes of medical cryology and have no com­
mercially available alternatives. The set allows for implementing multiple new techniques of 
cryotherapy and cryosurgery, which expands the horizon of possibilities of medical cryology. 
An essential advantage of the set is that all instruments can operate independent of the power 
supply, that is, in a standalone mode.
2. Cryogenic revitalization in cosmetology
It is indisputable that treating any pathological process on the skin and especially the facial 
skin should be performed with cosmetic method. First and foremost, these requirements are 
adequately met by cryogenic therapy methods. However, cosmetologists should not take 
them simplified and consider cryogenic exposures as the basic techniques having only func­
tional mechanisms of medical effect.
A great mistake in the activity management of beauty salons is to give charge over implementa­
tion of cryogenic procedures to the hands of nursing staff and such approach should be absolutely 
avoided. Cryogenic techniques intended for skin exposure are exclusively medical procedures.
When working with cryo-exposure techniques, we need to remember that liquid nitrogen is 
not the same piece of ice like a chamomile infusion frozen in a domestic refrigerator, which 
can hardly injure the facial skin look. Only the non-contact volatile exposure to liquid nitro­
gen vapors can be absolutely safe. Any skin application, even very brief (especially if done 
with cotton wool soaked in liquid nitrogen), if applied in the presence of skin moisture or 
sebaceous secretions, in case of sensitive or aging skin, will lead to adhesion, uncontrolled 
heat transfer, glaciation in the form of a solid spot and can end eventually with the formation 
of bubbles, necrosis, hyper- and hypopigmentation, and subsequently to hyperplastic scars.
To avoid such implications and create deep regenerative pulses in the skin through the actual 
formation of interstitial ice, the best proven technique is used and tested in clinical practice 
for many years—a technique of deep rejuvenation by cryo-kneading with special tampons 
with mesh embossed surface (“Method of cryogenic treatment of skin,” a technique devel­
oped by Dr. V.I. Kochenov). It prevents the accidental creation of a drain freezing zone on 
the skin, which would have ended in the development of cryonecrosis and complications are 
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almost excluded. The objectives can vary very widely, from mild stimulation of blood supply 
and reviving complexion during the day or before going to the theater, to the elimination of 
hyperpigmentation and superficial keratoses, elimination of fine mesh of wrinkles, and skin 
smoothing in 3–4 weeks after the procedure. It depends on the degree of exposure, velocity 
of skin kneading performed with the tampon chilled in liquid nitrogen, and the number of 
cryo-exposure repetitions at a particular site.
Therapeutic effects come even from a very short-term skin freezing: exfoliation of the upper 
skin layer is facilitated; skin pores are reduced; blood vessels’ tone is increased, and produc­
tion of the innate skin collagen is stimulated. Longer freezing destroys viral manifestations 
and pathogenic microbial associations.
To provide a focused local effect, any cryo-spray device is suitable, if the distance to the tissue 
surface is increased and manipulation is performed in a pulse mode with close visual inspec­
tion of the treated surface.
The workplace of cryo-cosmetologist should be equipped not only with cotton sticks and a 
vacuum flask. To perform any cryological therapeutic intervention, destroying pathological 
tissue with a wadding stick is simply careless in our days.
The objective of the suggested method of cryogenic skin exposure described in this book is 
to provide a pronounced and persistent medical cosmetic effect without the risk of complica­
tions. The proposed method ensures:
• marked and long-lasting therapeutic cosmetic effect;
• possibility to control the treatment quality and effectiveness, due to the available clear cri­
teria for assessing the zone and timing of cryo-exposure;
• excluded formation of skin vesicles and bullae;
• individual and differentiated approaches to treatment;
• rapid and non-traumatic freezing of the upper skin layers;
• dosed, with the possibility of precise localization and, ultimately, uniform and deep skin 
freezing;
• creation of discrete linear, non-merging freezing zones, with the direct formation of inter­
stitial ice;
• complete cryosurgical destruction (cryodestruction) of individual minor pathological, exo­
phytic and diffuse formations, and pigmentary changes; and
• possibility of multiple actual skin freezing without the risk of complications and cosmetic 
defects after the procedure.
A beauty salon that offers cryological procedures in its list of services needs an accessible 
set of devices to implement medical cryology techniques for facial skin rejuvenation. To per­
form cryoablation of pathological formations, cryo-cosmetologists are recommended to use 
“Ledok” (Icelet) unit with cannulae of different diameter.
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The proposed set of spherical cotton tampons retain their elasticity at liquid nitrogen tem­
perature and are encapsulated in natural fabric (textile—cotton, wool—with a checkered 
relief (waffle) structure, or braided, netlike, perforated leather). Capsules should have cells 
of different size, for example, a structure where the wall thickness between the cells does not 
exceed 1/10 and the cell depth—1/5 of the cell side, respectively. Diameter of applicators can be correlated conveniently with the known morphological features of the human face, for exam­
ple, the size of the optic fissure. The set should include tampons of at least three sizes, with 
diameters corresponding to the entire length, 1/3 and 1/5 of the patient’s optic fissure. Capsules for three tampons of the same diameter are selected in such a way that the cell size for each 
tampon makes 1/10, 1/20, and 1/30 of its circumference, and this pattern is kept for tampons of all three diameters, as follows from their practical use. A cotton wad is tightly crumpled, covered 
with a piece of textile under tension to form a ball-shaped tampon. The tampon is fixed, for 
example, by capturing the gathered textile elements in the proximal part of the tampon with 
a surgical clip on a thermally nonconductive handle.
2.1. Cryo-exposure procedure
Before starting treatment, the patient’s skin is treated with an alcohol-free facial cleanser. 
Then a moisturizer is applied to the skin and gently rubbed in a circular motion. Wait for 
10–15 minutes.
The first step is the pointwise cryodestruction of pigmented spots and minor benign skin 
tumors (papillomas and hemangiomas) by special applicators.
Then all tampons are immersed in the working container with liquid nitrogen. When rapid 
boiling of liquid nitrogen is stopped, tampons are ready for use.
Next, the tampon of the largest diameter and the largest cell size is taken from the liquid 
nitrogen and its excess is removed from the tampon. This tampon is used for test applications 
on the places, where the skin surface is the smoothest: the forehead or the chin. The tampon 
is rolled with its lateral surface, applying a gentle pressure on it and stretching the skin. The 
handle should be oriented at a very acute angle to the skin surface, thus making the rotation 
of the tampon archwise, almost by 180°,. Thus, the tampon is rolled by a distance approxi­
mately equal to the half of its circumference. The average time of the tampon move is selected 
from 2–3 to 3–5 seconds depending on the skin type (sensitive or oily skin). After completing 
rotational rolling, the tampon leaves behind it an ellipsoidal relief imprint—the freezing zone. 
The surface of this zone is examined using a binocular magnifier and fiber optic lighting, and 
its characteristics are evaluated.
Next, two to three test applications are performed in the same way, rolling the tampon at 
different velocity, changing the angle of the handle and under control of thawing time, 
which should not exceed 1–3 seconds. Then the visual characteristics of the resulting zones 
are compared and the optimal rolling speed is selected, for which the freezing zone struc­
ture fully corresponds to the characteristic pattern of the tampon capsule. Upon completed 
cryomassage, the imprint fully disappears from the skin surface, due to the natural heat 
uptake.
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Cryomassage of the face, neck, and décolleté is performed with the optimal selected velocity, 
following the basic rules:
• a single, one-time selected tampon is used for three to five applications; then it must be 
cooled by immersing in liquid nitrogen for 5–10 seconds, squeezed out and used further;
• the rolling direction during the cryo-exposure on the same section of the skin surface is 
changed along the line of visible skin folds and in short movements perpendicular to them.
When all the desired skin areas are subjected to cryo-exposure with a tampon of 1/10 circumfer­ence cell size, the same areas are treated with tampons of 1/20 and then 1/30 circumference in the same way. As a result, a marked skin hyperemia appears 5–10 minutes after exposure, which 
is manifested in elongated spots on the places that were first subjected to cryo-exposure. 
During repeated massage of cryoapplications on hyperemic skin areas, the rolling velocity 
should be slightly reduced, and the freezing time in each point of the skin surface should be 
increased, respectively. Subsequent cryo-massage applications are oriented to those areas, 
where the hyperemia is less pronounced or has not yet developed.
Cryomassage for the less accessible facial skin areas (parotid region, nose bridge and wings, 
around the nostrils, around the lips, upper and lower eyelid, and eye corners) should use 
applicators as follows.
First, cryo-manipulations are performed with tampons of the large cell size: a tampon with 
a diameter of 1/3 of the optic fissure is applied to the skin in the superciliary region, the nose bridge, the parotid region, and around the lips; a tampon with a diameter of 1/
5
 of the optic 
fissure is applied to the skin around the nose wings, the nostrils, eyelids, and the internal and 
lateral angle of the eye; cryo-manipulations along the line of the most pronounced skin folds 
are performed with the same tampon. In doing so, the skin is stretched preliminarily with 
the other free hands in the direction perpendicular to the tampon rolling line, smoothing the 
wrinkled tissues and opening the skin folds for cryo-exposure. Ensure that the checkered 
relief freezing zone is formed on the stretched skin areas. Then cryomassage applications are 
repeated with tampons of the smaller cell size in the same way.
The relief zones of cryo-exposure performed with tampons of different sizes should over­
lap with no absolutely distinct boundary between them. Continuous “checkered” microfocal 
real freezing ensures repeated cryo-exposure on the same skin area without risk of blisters 
appearing after the procedure. A clinical sign of an adequate cryo-exposure is the develop­
ment of persistent and uniform skin hyperemia. A high-quality cryomassage of face, neck, 
and décolleté lasts from 40 minutes to 1 hour.
Immediately after completion of the procedure, nourishing and regenerating products in the 
form of cream or gel should be applied on the hyperemic skin and relevant medications—to 
the sites of pathological diffuse lesions (acne). Skin cryo-session can be repeated not earlier 
than in a month.
Currently, cryolifting techniques for the interstitial correction of manifestations of gravita­
tional ptosis on the facial skin by linear subcutaneous cryo-exposure are under development. 
The outcome of treatment is presented in Figure 1.
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3. Multiple cryogenic treatment for psoriasis
Psoriasis is a chronic multifactorial systemic disease characterized by epidermal-dermal pap­
ular rashes. It occurs with equal frequency in males and females and persists over the years 
with alternating periods of remission and relapses. It is one of the most common, refractory, 
and often severe dermatoses. The effective treatment of psoriasis requires considerable efforts 
but in many cases it comes untenable.
When treating mild forms of psoriasis, dermatologists tend to use the least toxic medications 
and treatment methods with the lowest risk of possible side effects. If the treatment goals 
are not achieved, other potentially more effective treatments can be tried but those are more 
toxic and have a higher risk of serious side effects. Such methods are typically reserved for 
severe cases resistant to other, less toxic treatment methods for psoriasis. This is referred to as 
“therapeutic intervention ladder.”
The etiology and pathogenesis of psoriasis is not yet fully identified. Currently, there are 
two main hypotheses about the nature of the process leading to the development of this 
disease. According to the first hypothesis, psoriasis is a primary skin disease, when normal 
processes of maturation and differentiation of skin cells are interrupted and the excessive 
proliferation of these cells is observed. The defenders of this hypothesis view psoriasis as a 
disrupted function of the epidermis and its keratinocytes. The second hypothesis assumes 
that psoriasis represents an immunopathological or autoimmune disease, where the exces­
sive growth and reproduction of skin cells and, particularly, keratinocytes are secondary in 
regard to various mediators of inflammation, lymphokines, and cytokines produced by the 
immune cells and/or in relation to the autoimmune damage of skin cells causing the second­
ary regenerative response.
Figure 1. Facial skin in a female patient (a) before and (b) after cryogenic revitalization.
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Genetic determination of psoriasis has never been disputed by medical experts and the exten­
sive clinical experience proves it. Many genes associated with or directly involved in the 
emergence of psoriasis are discovered but it still remains unclear, how these genes interact in 
the development of the disease. The majority of genes known to be associated with psoriasis 
affect the immune system in one way or another, particularly, the function of T lymphocytes 
and for the major histocompatibility complex (MHC).
So far, the viral theory of the origin of psoriasis is controversial and gives rise to a number of 
scientific publications, both in favor of this theory, and against it. According to V.I. Kochenov, 
it is the viral nature of psoriasis, with its patterns of development of clinical manifestations 
similar to those for papillomavirus that justifies the exclusive adequacy of cryogenic treat­
ment for multiple benign foci of psoriasis.
Indeed, the cryogenic technique allows sparing devitalization of psoriatic lesion, attribute 
antigenic properties to it, with spontaneous natural phagocytosis, rejection of modified cells 
and the immunostimulatory effect. At the same time, it provides a possibility of simultaneous 
radical cryodestruction for the large number of foci on a large area of skin surface without the 
negative reactions of the entire organism. Moreover, cryogenic treatment stimulates immune 
activity against the modified cells by performing cryotherapy of the lymphoid pharyngeal 
ring and the total extreme aerocryotherapy.
The cornified cells in the superficial skin layers form the stratum corneum. It is particularly 
pronounced in the psoriatic lesion and this explains for its considerable elasticity and low 
thermal conductivity. Special cryoablation techniques are needed for the efficient cryotherapy 
of psoriatic foci and to stimulate the regeneration of the normal skin cover.
3.1. Cryo-exposure procedure
A full course of successful cryogenic treatment for psoriasis was developed in “OnKolor” 
Scientific Clinical Center of Medical Cryology. It is important to keep in mind that local cryo­
genic exposure needed for the complete elimination of the psoriatic focus cannot be referred to 
as cryotherapy. This should be a proper cryosurgery performed in line with the rules of tumor 
cryodestruction but less deep penetration of the freezing zone into the pathological tissue.
Therefore, a combination of techniques is applied in cryoablation of psoriatic foci (even if a 
single focus is treated):
1. Continuous cryo-irrigation with liquid nitrogen until a stable, visible for 5–10 seconds, 
icing of the entire surface of the psoriatic focus occurs, with two to three iterations of the 
freeze-thaw cycle at each site during one procedure.
2. Prolonged exposure, with a slow rolling of the cotton wool tampon with braided mesh-like 
surface chilled in liquid nitrogen on the focus, until a stable, persistent for 4–5 seconds, vis­
ible freezing of the psoriatic lesion occurs.
3. Cryoapplication without adhesion performed with passively or actively chilled cryo-in­
struments by straightening the focal surface and consecutive stops of the applicator for 
2–5 seconds at each site.
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4. Stepwise freezing of the entire lesion surface by touching with a drop of atmospheric oxy­
gen passively liquefying on the lateral side of the non-thermally insulated cannula and 
flowing down to “Ledok” cryoapplicator.
It should be noted that in the first two cryodestruction options, psoriatic lesions reveal an 
increased rate of the surface freezing.
To enhance cryodestruction and increase the cooling rate prior to the cryo-exposure, a mix­
ture of glycerol and dimexidum 40% solution or soft magnetic dosage forms (SMDFs) should 
be applied to the focal surface and in this case, a permanent magnet is placed around the 
freezing area.
Thus, one psoriatic lesion is subjected to three freeze-thaw cycles, in line with the above 
described cryodestruction techniques. Repeated cryo-exposure procedures should be contin­
ued until the complete elimination of psoriatic plaques. Complete persistent elimination of 
dermal psoriatic manifestations can be reached after three to four adequate cryodestruction 
operations for all psoriatic lesions but may require 5–7 sessions.
The course of general extreme aerocryotherapy (GEACT) included in the cryogenic treatment 
complex for psoriasis is carried out in “Krion” cryosauna, as follows:
• three procedures per day, simultaneously with the start of the local treatment;
• next, four procedures every other day;
• then one procedure once a week for three weeks; and
• then one procedure per month, up to a year.
Usually GEACT course includes 10–15 sessions.
By the end of a combined treatment course, the remaining minor psoriatic lesions should 
be impregnated with a mixture of glycerol-dimexidum 40% before the GEACT session. 
Cryogenic treatment is well tolerated by all patients and has no contraindications.
To enhance the activity of the immune status, local cryodestruction of psoriatic plaques 
should be supplemented by cryotherapy of the lymphoid pharyngeal ring.
Subject to compliance with these cryogenic treatment recommendations for psoriasis, the 
patient’s skin stays clean for the period of 1–3 years. However, if there is a slightest tendency 
to recurrent psoriatic lesion, this site should be immediately subjected to the superficial cryo­
ablation. The outcome of treatment is presented in Figures 2 and 3.
4. Cryosurgical treatment for warts
Warts are benign skin tumors based on the proliferation of the epidermis and papillary der­
mis. Warts are caused by the human papillomavirus, which is passed only between humans. 
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Figure 2. Plaque psoriasis vulgaris: (a) before and (b) after combined cryogenic treatment.
Figure 3. Palmoplantar psoriasis: (a) before and (b) after combined cryogenic treatment.
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There are more than 600 HPV strains. According to some estimates, 60% of human population 
carries this virus.
The following types of warts are distinguished: common, flat, genital, and senile. Common, 
flat, and genital warts are caused by a single virus. Common warts (verruca vulgaris) are the 
most widespread and contribute to over 70% of the total number of warts. For this reason, we 
will discuss cryodestruction techniques for this type of warts in detail.
Being the most reliable destruction mechanism damaging all pathological tissues along with 
preserving cosmetic result, cryosurgery is the best suitable method for the elimination of 
warts. A very important effect in the treatment of warts by deep freezing is ablastics of cryo­
destruction that blocks all the elements of the pathological focus and prevents the spread of 
newly formed wart viruses in the body. They remain in the exfoliated cryonecrotic scab and 
are removed mechanically from the body.
However, the wart structure is very peculiar, which puts a number of obstacles and compli­
cates cryogenic destruction of this skin formation. Its base goes deep into the tissue and its 
surface diameter makes always only a portion of the root depth. The wart capsule is dense and 
dry; the surface is cornified and tuberous, which prevents the proper heat transfer between 
the cryoapplicator and the pathological tissue.
Thus, the cryoablation technique for the common wart is the same as in the case of a malig­
nant tumor.
Wiping the wart surface with cotton wool soaked in liquid nitrogen does not refer to the 
radical cryosurgical techniques; such exposure is just too superficial. According to our experi­
ence, incomplete cryogenic destruction of wart tissue often stimulates its rapid growth and 
proliferation.
4.1. Cryo-exposure procedure
First, the wart is prepared by steaming its surface and the stratum corneum is removed 
mechanically to the greatest possible extent. Warts located on the hand back, foot, and the 
lateral surface of the finger are subjected to cryocompression destruction by capturing with 
transformation of the affected area into a fold using cryo-clamps with spatial heat accumula­
tors. The exposure time is needed to get the entire surface of the pathological focus and the 
area of 1–3 mm beyond its borders fully covered by the freezing zone.
This technique is absolutely nonapplicable on the palmar surface and the feet. The basic 
manipulation for cryodestruction of common warts in these locations is the applicative freez­
ing with adhesion using “Ledok” apparatus. Cryogenic treatment is continued until complete 
icing of the entire pathologically modified site within its borders.
Icing comes instantly together with the full-rate adhesive effect and freezing-in the working 
tip into the wart tissue. Therefore, mechanical contact and heat transfer are maintained at all 
absolute values of the subzero temperature, even after the true adhesive effect disappears. 
It persists even after the start of passively condensing ambient oxygen flow to the frozen 
surface via the lateral open surface of the cannula. This phenomenon is used at freezing 
temperature of −182°C.
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The exposure is continued until complete icing of the entire pathologically changed site and 
the creation of the freezing zone that extends beyond the borders of the skin formation, at 
a distance equal to its diameter. Only under such excess over the size of freezing zone, the 
pathological wart tissue is expected to be covered by destructive temperatures.
Freeze-thaw cycles for each wart are repeated three times, regardless of the cryoablation 
technique.
Another option for additional deep local cooling, appropriate for large-size common warts, 
is cryo-irrigation of the wart surface with the same parameters of freezing expansion area, 
which is carried out at the final stage. Cryo-irrigation as a single freezing method cannot be 
recommended for eliminating warts.
Genital warts, flat warts, and senile warts are subjected to cryo-compression destruction 
as described above, by using a cryo-instrument with spatial heat accumulators of the most 
appropriate size.
5. Cryosurgical treatment for purulent diseases of the skin and 
subcutaneous fat using SMDF in a magnetic field
Purulent diseases of the skin and subcutaneous fat account for about 70% cases in surgeon’s 
outpatient reception. The most common causative agent of these diseases is the staphylococ­
cal flora (70–90%).
The main purulent diseases of the skin and subcutaneous tissue include furuncle, carbuncle, 
hydradenitis, and abscess. Diseases complicated by lymphangitis and lymphadenitis take a 
particularly severe course. In addition to surgery, treatments of purulent diseases of the skin 
and subcutaneous fat use an intensive combined treatment: antibacterial, detoxification, and 
immunomodulation.
Following the rejection of a rod consisting of necrotic tissue and pus, ulcer-like skin defect 
is formed, is rapidly replaced with granulation tissue and healed by secondary intention, 
leaving a deep inverted scar. A cosmetic skin defect is often formed at the site of surgical 
wound.
In recent decades, active development of cryosurgery attracts particular attention, due to the 
creation of uncomplicated, reliable, and inexpensive cryogenic devices. An important factor 
is the elimination of the causative agent of purulent infection in the inflammation focus sub­
jected to freezing, with subsequent fixation of purulent focus by swelling of the underlying 
tissues and vascular thrombosis.
Currently, the cryogenic treatment for purulent diseases of the skin and subcutaneous fat is 
almost unused, despite its proven success, as described in some published works.
Obviously, difficulties arise during freezing pathological cavities. This situation can be 
addressed by the creation of heat-conducting liquid layer between the cryoapplicator tip and 
the freezing tissue, providing adhesion and congruence of surfaces. Traditional use of aqueous 
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layers, which are characterized by low thermal conductivity, impairs the main characteristics 
of the cryo-instrument, while oil- and alcohol-based layers have even lower heat conductivity 
and adhesion capacity.
Furthermore, healing under cryonecrotized biological tissue occurs in two main stages. First, 
necrotic tissue is transformed into long-drying moist cryonecrosis. Due to the fact that cell 
membranes are damaged by ice crystals formed during freezing, the intracellular fluid exu­
dates to the surface of cryonecrotic tissue, thus preventing the secondary infection of cryo­
necrosis. When the exudative process concludes, moist cryonecrosis turns into a solid dry 
scab—dry cryonecrosis. During this period, the epidermal cells regenerate from the periphery 
to the center. The time length of regeneration correlates with the focal diameter of the cryo­
genic lesion and its depth. During this period, the dry cryonecrosis covers the wound surface 
and acts as an antiseptic dressing.
Since the dry cryonecrosis has a much lower elasticity, as compared to the skin, it tears away 
during the healing process. This process is promoted by the natural partial exfoliation of dry 
cryonecrosis from the periphery as regeneration proceeds.
If purulent diseases of the skin and subcutaneous fat are subjected to superficial cryo-expo­
sure, microbial associations are often preserved in the pathological cavity. To avoid this situ­
ation, cryodestruction should be performed more intensively. An increase in the depth and 
area of cryo-exposure will inevitably result in a more extensive damage to healthy tissues and 
will significantly lengthen their recovery.
Such problems as an insufficient depth of cryo-exposure or a significant surface expansion 
of the freezing zone on healthy tissues in an attempt to increase the depth of the freezing 
area, the lack of effective heat transfer and the duration of postoperative period remain yet 
unresolved and restrict the application of the cryogenic method in the treatment of purulent 
diseases of the skin and subcutaneous fat.
A new class of pharmaceuticals that appeared in recent years includes preparations that have 
high thermal conductivity and are capable of penetrating into small cracks, pores, caverns, 
ducts, and various cavities in the presence of magnetic field, which enables a wider use of the 
advantages provided by the cryosurgical treatment.
SMDF is a pharmaceutical form containing fine particles of magnetized ferromagnetic 
(Fe2O3–Fe3O4, SrO∙6Fe2O3, Nd–Fe–B, FeB). SMDF consistency, viscosity, and fluidity depend on concentrations of ferromagnetic and the base substance. As the strength of magnetic field 
increases, SMDF thermal conductivity approaches that of the metal, i.e., SMDF is in fact a soft 
metal body. It comes important with regard to the fact that thermal conductivity increases 
in cryo-exposed pathological tissue and subsequently, the destructive effect of cryoablation 
is enhanced.
Moreover, SMDF applied locally has pronounced antiseptic and dehydrating effects, which 
are essential in the postoperative period to reduce the moist necrosis phase and accelerate the 
regeneration under dry cryonecrosis. These effects can be supplemented, if necessary, by the 
introduction of anesthetic, hemostatic, vasoconstrictive and other medications into the SMDF 
composition.
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5.1. Cryo-exposure procedure
Cryosurgical treatment of patients with purulent diseases of skin and subcutaneous fat does 
not include the general antibacterial therapy.
Antibacterial agents are applied only locally in ointment. To enhance skin susceptibility 
to penetration of all SMDF components, dimexidum (dimethyl sulfoxide, 40% solution) is 
included in the ointment composition.
During the infiltration stage, SMDF is applied to the entire zone of hyperemia, the cryoappli­
cator is brought into contact with the magnetic ointment, and cooling is performed until the 
freezing zone is spread to the uninflamed skin. Under such short-term cryo-exposure, super­
ficial cryonecrosis is formed, not deeper than 1.2 mm (Figure 4).
A sharp pain in the inflammation focus perceived by patients prior to the cryo-exposure 
therapy is arrested. Edema and hyperemia of the infiltrate that develop within hours after 
cryoablation disappear in the first 2–3 days. Necrotic tissue has an intense dark brown color, 
due to the admixture of ferromagnetic particles.
In the postoperative period, magnetic ointment should be replaced daily, simultaneously by 
applying magnetic fields to the focus of inflammation. The thin cryonecrotic layer is rejected 
within 7–10 days, depending on the area of cryonecrotized tissue.
During the necrosis stage, cryo-exposure is performed until the freezing zone is spread on the 
healthy tissue, then the edema of subcutaneous fat in the entire depth of the abscess is developed 
in 20–30 minutes. When swelling is observed below the focus of purulent inflammation, the 
pyogenic abscess is dissected. Pus and necrotic content are removed from the furuncle cavity by 
washing with 0.9% isotonic solution. Then, SMDF is injected in the abscess cavity with a syringe.
Figure 4. Spread of the freezing zone produced by the traditional cryoablation and by SMDF in a magnetic field.
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Magnetic fields generated by the permanent magnets promote the maximum penetration of 
the ointment into the abscessed cavity. A cryoapplicator is brought into contact with a fer­
romagnetic ointment on the abscess surface and it starts cooling. Thus, the cavity is frozen 
inside by using SMDF as a thermally conductive material. At the same time, the effect of 
magnetic field should not be interrupted, in order to enhance thermal conductivity of the 
ointment.
In the postoperative period, most ointment is removed spontaneously together with the exu­
date. The ointment residues are removed from the abscess cavity with a cotton tampon and a 
permanent magnet, and then fresh ointment is introduced with a syringe. During the wound 
healing, ointment containing the antibacterial agent should be applied on the surface of the 
cryonecrotic tissue. As regeneration goes, the wound healing occurs by the day 7–10, without 
scar formation.
In the open abscess stage, the cavity is flushed with 0.9% aqueous solution of sodium chloride to 
evacuate necrotic masses, with the subsequent cavity filling by SMDF, performing cryo-expo­
sure and maintaining the postoperative period in line with the above described procedure.
The experience of magnetic ointment applications proved that SMDF allows for establishing a 
tighter thermal contact between the cryo-instrument and the tissue, to accelerate cooling and 
increase its depth, due to higher thermal conductivity of SMDF, and to intensify frost penetra­
tion into the deep tissue, due to the active SMDF penetration into the pathological substrate.
Applying additional SMDF on the abscess surface in the postoperative period reduces the 
periods of moist and dry cryonecrosis, due to the stimulation of regenerative processes.
The postoperative use of magnetic ointment makes possible exclusion of systemic antibiotic 
therapy, eliminates formation of cosmetic defects on the skin and prevents the development 
of complications.
It is particularly important that the cryosurgical method using SMDF provides absolute elimi­
nation of pyogenic bacteria, particularly, methicillin-resistant Staphylococcus aureus (MRSA) 
resistant to traditional methods of antibacterial treatment.
6. Cryosurgical treatment for epithelial cysts
Epithelial cyst is a cavitary lesion developed from the epidermis; its capsule produces the 
mass filling of the cyst. Epithelial cysts of the skin are classified into several types depending 
on their microscopic structure: epithelial (epidermal), dermoid, and trichilemmal cysts.
Epithelial cysts are traditionally treated with surgical methods. Cystectomy implies the exci­
sion of the entire cyst capsule together with the intact surrounding tissue through cuts outside 
of the cyst. Under pyogenesis, the cyst is first subjected to oncotomy only and cystectomy is 
performed when inflammation decreases. This treatment leads to a cosmetic defect in the 
form of scar and pyogenesis poses another problem—completeness of the capsule removal, 
when its remains to create conditions for disease recurrence.
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Cryosurgical treatment for epithelial cysts eliminates the occurrence of relapse and improves 
cosmetic result of the operation. A set of instruments for medical cryology suggested by Dr. 
V.I. Kochenov is intended for the efficient implementation of various techniques of deep local 
cryoablation of various cysts localized visually. Instruments and methods should be used 
differentially at different stages of the operation depending on the cyst size and its location/
depth.
6.1. Cryo-exposure procedure
Prior to the start of cryo-exposure, the surgical field is treated with antiseptic and the skin is 
irrigated with 10% lidocaine solution.
For cysts of less 8 mm in diameter, with their content visible through the skin or mucosa, cryo­
compression destruction is performed by capturing pathological tissue in the fold with cryo-
grasp accumulators cooled passively in liquid nitrogen. After the first freeze cycle, the cyst 
cavity is perforated by a pointed cryostick cooled in liquid nitrogen during spontaneous 
thawing phase. In the next cryocompression freeze cycle, the cyst content should be evacu­
ated by bringing together cryoaccumulators to the closest possible position. Thus, two freeze-
thaw cycles are performed under tight pressing of collapsed cyst walls to each other and with 
the time of cryo-exposure equal to 3–5 seconds.
For cysts of up to 1.5 cm in diameter and transparent contents, cryodestruction with adhesion 
is performed with “Ledok” cryodevice with active supply of liquid nitrogen. The exposure is 
continued until the freezing zone extends 1–2 mm beyond the projection of the cyst diameter 
from all sides. During spontaneous thawing and some softening, a linear incision, 4–6 mm 
long, is performed with a scalpel, with penetration into the cyst cavity and its content is 
removed with a Volkmann spoon. Then a warm rounded applicator sized to the diameter of 
the cyst cavity is inserted through the produced hole, as if the cystic bag is put on the cryo­
applicator. The operation is carried out in two to three freeze-thaw cycles, cryo-exposed for 
5–10 seconds and under palpation control.
For cysts of up to 1.5 cm in diameter and nontransparent content, cryo-exposure is performed 
through applications with active cryoapplicator adhesion or by pulse cryo-irrigation onto the 
projection of the cyst center with 2–3 mm extension of the freeze zone beyond its borders. 
Without waiting for complete thawing, incision is made with a warmed scalpel (or focused 
radiation CO2 of laser/RF scalpel) in the projected cyst center with penetration into the cav­ity, in order to evacuate its content during the thawing phase. In the process of thawing, the 
cyst is emptied and then dried. Next goes cryo-insufflation of the cavity using the cryo-spray 
device. Cryodestruction is completed by cryocompression freezing under tight pressing of 
the collapsed cyst walls. The exposure is continued until the freezing zone is established at 
2–3 mm beyond the cyst borders.
For cysts with a thin capsule and provided that the rounded cyst shape is not regained after 
compression, the operation is finalized at this stage and pressure dressing is applied.
For cysts with a dense capsule, multidirectional cryo-irrigation is carried out within the cystic 
cavity prior to its icing. After thawing, a warm cryoapplicator with a protective insulating 
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element with axial displacement is introduced into the cyst cavity. The free distal tip of the 
applicator is placed into contact with the cavity bottom and liquid nitrogen is applied briefly 
until adhesion appears. Then traction is performed with a cooled cryoapplicator in rotational 
clockwise motion, thus reaching full excision of the epithelial cyst capsule, and the operation 
is completed.
In the presence of inflammation or purulence, the cyst is dissected with a cryo stick chilled in 
liquid nitrogen, its content is evacuated, the cavity is washed with chlorhexidine 0.05% aque­
ous solution and dried. Then, a warmed “Ledok” cryoapplicator of the appropriate size and 
with active supply of liquid nitrogen is inserted into the cyst cavity and the cystic capsule 
is subjected to cryodestruction with adhesion, performing three freeze-thaw cycles, with an 
exposure time of 5–10 seconds and under palpation control.
When the cavity diameter is larger than the cryoapplicator, it is filled with the soft ferro­
magnetic heat-conducting ointment or gel (a 20% mixture of nano-ferromagnetic particles 
of carbon iron in antiseptic ointment or gel base) and then the applicator is dipped into it. A 
ring-shaped permanent magnet should be placed around the cyst projection. Freezing with 
adhesion is carried out until the freezing zone is spread 2–3 mm beyond the cyst capsule in all 
directions, in three freeze-thaw cycles.
When the cyst cavity diameter is much larger than the applicator, it should be moved with 
pressing to different sites of the walls until icing, in order to ensure at least triple freezing of 
each site of the cyst capsule and surrounding soft tissues.
Cryosurgical treatment for epithelial cysts allows to:
• guide surgical interventions directly onto the cyst projection and into its cavity, rather than 
around it, thus reducing the width of the surgical field and the incision;
• ensure radical treatment through the absolute destruction or complete and quality removal 
of the entire capsule;
• eliminate the cause of recurrence;
• perform cryo-exposure in a differentiated mode depending on the size, depth of the cyst 
location, as well as the capsule thickness;
• provide ice fixation of the cyst capsule at the moment of its dissection;
• prevent formation of a scar and cosmetic defects; and
• achieve the absolute elimination of pathogenic flora under inflammation and purulent dis­
solution of the cyst content, simultaneously with its removal.
Thus, cryosurgical treatment for epithelial cysts is acceptable both in non-inflammatory and 
purulent conditions. A thin cyst capsule is easily subjected to the total cryoablation, whereas 
thick capsules of larger cysts are better treated by cryo-excision. This technique allows for a 
radical treatment, which excludes relapse in the long term. In addition, cryosurgical treat­
ment of epithelial cysts provides a good cosmetic effect. In the course of the epithelial recov­
ery, the cryo-necrotic scab is rejected gradually layer-by-layer, without scarring.
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7. Cryosurgical treatment for skin hemangiomas
Hemangioma is the most common benign tumor formed by blood vessels. This tumor devel­
ops, due to the unrestrained growth of defective blood vessels, which are arranged randomly, 
fail to perform blood circulation in tissues and organs, and form a tumor [1, 2].
The results of various treatments for skin hemangiomas are not always satisfactory for 
the patients and doctors. Relapses and cosmetic defects are observed commonly after the 
treatment.
Application of cryogenic treatment to skin hemangiomas was limited by the lack of adequate 
cryo-instruments needed for the effective cryoablation. The available cryogenic equipment 
was used in the treatment for extensive large hemangiomas located in the parenchymal 
organs, whereas there were no targeted developments for the treatment of cutaneous hem­
angiomas. Previously, application techniques were widely used for this purpose. However, 
recent developments made a step forward to the use of cryosurgical methods for treating skin 
hemangiomas of any localization and of different sizes.
The instrument, which proved the most optimal in cryosurgery of hemangiomas, was 
manufactured by the order of Cryology laboratory, Department of operative surgery and 
topographic anatomy, Nizhny Novgorod State Medical Academy, and was included in the 
Medical Cryology Set proposed by Dr. V.I. Kochenov [3].
The instrument is made of a metal alloy with high heat capacity allowed to be passively 
cooled in liquid nitrogen. It comprises movably connected jaws with ring-shaped handles; 
their working parts, from the place of joint to the distal tip, are made spatial, with the pos­
sibility of closing the working surfaces relative to each other. When closing, the outer surfaces 
of the jaws’ working parts are oval-shaped; the distal tip is sharpened at an angle of 30–35° to 
the closing plane; the length of each is 30 mm (can range up to 40 mm). The greatest convex 
extension of jaws corresponds to the middle of the oval and makes 1/
5
 of its length. Capillary 
slit-like grooves for penetration of liquid nitrogen are made in the deep working part of jaws 
and are directed to its distal parts. All instrument surfaces are polished.
7.1. Cryo-exposure procedure
When performing cryoablation, the internal surfaces of working parts of jaws act as applica­
tors and the exophytic part of hemangioma is clamped between them. If the hemangioma is 
flat, i.e., is located deep in the skin, it is captured in a skin fold, so that the entire formation is 
fixed between the jaws and the slit grooves are directed up and down. Liquid nitrogen flows 
via grooves to the hemangioma and enhances freezing. When performing cryo-exposure, the 
hemangioma is compressed by 1/2–1/3 of its diameter; then, it is slightly retracted and rotated to an angle of up to 45° to the skin surface. When the freezing zone is expanded to 5 mm beyond 
the perimeter of the tumor base, the contact is ceased and the instrument is removed. After 
complete spontaneous thawing of the hemangiomas, all manipulations are repeated thrice in 
the same order. After freezing of the hemangioma tissue, cryobiopsy for histological examina­
tion should be taken.
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The time of cryo-exposure to liquid nitrogen may be different in each case; the average value 
is 60 seconds. All capillary skin hemangiomas of any location, sized up to 3 cm2, regardless of 
their number, are recommended to cryo-exposure in a single session.
The advantages of cryosurgical treatment for hemangiomas are as follows:
• wide range of indications (no restrictions on age, number, location, size, and morphologi­
cal type of hemangiomas);
• no limitations on the volume and number of hemangiomas subjected to simultaneous cryo­
ablation; and
• good cosmetic results after treatment (rehabilitation of the normal skin color and structure 
without scarring and depigmentation). The outcome of treatment is presented in Figure 5.
8. Cryosurgical treatment for precancerous skin lesions
The term “precancer” was introduced by the French dermatology researcher N. Dubreuilh 
over a hundred years ago. This term denotes the processes that precede the development of 
a malignant tumor but not always result in cancer formation. Further in 1933, S.C. Becks sug­
gested the division of precancerous conditions into the obligate and facultative.
Under obligate precancerous diseases, skin changes are characterized by the oppositional 
type of growth and their reverse development is not observed. In the current world literature, 
local malignant processes that do not spread beyond the skin cover are described commonly 
as carcinoma in situ.
Under facultative precancerous conditions, cornification of the mucous membrane and stro­
mal inflammation are observed. The greatest significance in the genesis is attributed to the 
cell hyperplasia, which differs from regeneration by the fact that it goes beyond the physi­
ological needs and transforms into dysplasia. Dysplasia has three stages—strong, medium, 
and weak; of those, the first represents a reversible process already with some signs of mor­
phological anaplasia, the second comes close to a tumor, and the third sometimes cannot be 
distinguished from it. All these clinical signs should raise cancer alertness.
Figure 5. Hemangioma on the breast skin: (a) before and (b) after cryodestruction.
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According to WHO experts, the recent and predicted increase in the incidence of malignant 
skin tumors is explained by the characteristics of the skin being the most exposed to unfavor­
able exogenous factors organ. The foci of superficial dyskeratosis very often contain human 
papillomavirus of strains HVP-16, HVP-31-35, HVP-51-54, and others. Histological examina­
tions of precancerous skin lesions reveal inflammatory and hyperplastic processes.
The number of skin and mucosal tumors increases with high malignant potential and this 
confirms the current need in methodological improvements in early detection technologies, 
timely and adequate treatment of patients with visually localized tumors with a high ten­
dency toward malignant transformation.
In this context, such advantages of cryosurgery as affordability, effectiveness, minimal inva­
siveness, possibility of geriatric application, ablastics, organotypic regeneration, as well as 
triggering the general immune-stimulating antitumor effect by preserving nativity of patho­
logical protein and nucleic acid structures of the rejected tumor are particularly important.
Unlike the most common minimally invasive treatment techniques—electrocoagulation and 
laser destruction—cryoablation features the delayed necrosis development, which allows 
obtaining a section of the frozen, i.e., non-viable tissue suitable for morphological examination.
The antitumor immunostimulatory effect is triggered against the neoplasm subjected to cryo­
ablation and preserved at the time of cryonecrosis formation. According to Dr. V.I. Kochenov, 
the effective induction of specific antitumor immunity is achieved by introducing a natural 
immune stimulation into the mechanisms of the general therapeutic and prophylactic antitu­
mor effect during cryoablation.
However, cryoablation is often applied to neoplasms diagnosed by inspection only, without 
morphological examination. This situation complicates the problem of their quality treatment. 
In dermatology, morphological examination plays an important role in dyskeratosis diagnos­
tics, whereas cancer diagnosis lacking morphological verification is considered nonvalid.
Special attention should be paid to the eczema-like skin lesions accompanied by itching, 
burning and pain, unevenly colored spots with scaling phenomena, focal plaques with moist 
velvety surface and areas of hyper- and hypopigmentation, focal changes with erosions, 
ulcerations and nodules, plaques covered with dry rough scales resembling psoriatic plaques, 
focal skin lesions with blurred contours, and a tendency to peripheral growth. Such focal 
transformations of the skin should never be subjected to an intervention without morpho­
logical diagnosis and they require radical treatment. Histological examination of these tissue 
fragments should be conducted after preliminary cryoablation.
The quality of histological examination, clinical and histological diagnoses, as well as selec­
tion of further treatment and the overall cosmetic result depend on a properly performed 
biopsy. However, the potential of morphological diagnosis for cryology is underutilized by 
dermatologists and cosmetologists. To solve this problem, cryodestruction should be com­
bined with biopsy that would improve significantly the quality of diagnostics and treatment 
of precancerous skin conditions.
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The temperature regimes of cryoablation are not yet standardized; the applicator’s tempera­
ture ranges from −60 to −180°C in different devices, which affects the cryoablation quality and 
prevents comparing cryoablation results obtained for similar pathological changes by differ­
ent authors. In some cases, treatment of precancerous skin conditions is attempted by applying 
cotton wool soaked in liquid nitrogen, despite the fact that this technique is inapplicable even 
for superficial therapeutic cryo-exposures, since the temperature in the contact zone (cotton-
pathological tissue) does not fall below −20°C. Therefore, in cryosurgery of precancerous skin 
diseases, we need to find a way for standardization, in regard to the intensive destructive effect 
and visualization of the lowest temperature of cryoapplicator used for tumor destruction.
Another unresolved cryoablation problem is how to determine the completeness of cryo-
destructive effect at early stages. Today, the completeness of cryo-destructive effect is most 
often determined visually by the presence of a tumor residue, 1–1.5 months after the full 
cryonecrosis rejection, which is absolutely unacceptable in case of malignant neoplasia. 
During the period of cryonecrosis rejection, the tumor can grow significantly and even spread 
metastases.
The current recommendation in cryosurgery is to achieve the expansion of the freezing zone 
2.5 cm outside the visible tumor borders is only a safety net when the cryoapplicator in use 
has an insufficiently low temperature and contains no objective productivity criteria for cryo­
destruction in any pathological focus. There are no available literature references about the 
early criteria for localization of the prospected cryonecrosis rejection line to be defined mor­
phologically in the first days after cryodestruction.
To address these objectives and in order to improve the quality of treatment for precancerous 
skin diseases, the major conditions should be implemented:
• to develop visualized standardization for the intensity of cryogenic destruction of the path­
ological tissue; and
• to ensure monitoring of early adequacy of cryodestruction volume for various tumors, 
along with defining the projected borders of the deep cryonecrosis zone.
These objectives are achieved through the following steps. Cryoablation is performed in at 
least two freeze-thaw cycles with adhesion and cover all clinically defined tumor volume by 
the freezing zone. The working part of the instrument should be cooled to below −182°C, as can 
be evidenced by visible liquefaction of atmospheric oxygen fraction. The next step is excision 
of the pathological tissue for morphological examination within 6–12 hours after cryoablation. 
The fragment is removed with a warmed scalpel (or CO2 laser, RF-scalpel) via oval cuts in the direction of possible infiltrative growth. The cut is made in a single block that includes the 
frozen tumor tissue and non-frozen ambient healthy tissues surrounding the freezing zone.
After that, local freezing for hemostasis is performed in the defected area of  the tumor bed 
and then a series of column biopsies is carried out along the tumor radius line, in the direction 
of the most probable latent growth, with access to the clinically healthy tissue in depth and 
to the periphery.
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Histological examination of the excised tissue fragments and in a series of column biopsies 
involves morphological identification of tumors and comparison between the boundary of 
pathological changes and the boundary of small blood vessels thrombosis on the surface and 
in depth. If the zone of pathological changes does not extend beyond the borders of thrombo­
sis, the cryogenic destruction of a tumor is considered complete, otherwise additional, deeper 
and broader cryodestruction is performed and cryo-extirpation is applied to the transformed 
site. Additional cryodestruction is carried out in such a way that the freezing zone overlaps 
the borders of pathological changes identified by histological examination.
In 6–12 hours after additional cryodestruction, the tissue fragments are excised for repeated 
morphological examination using the same methodology as earlier. Then a series of biopsies 
is taken along the radius line of the tumor in the direction of the latent growth detected histo­
logically, with access to clinically healthy tissues. After removing the column tissue fragment 
and if hemostasis is needed, cryo-exposure is performed inside the channel by cryo-insuffla­
tion or by inserting the cryoapplicator of appropriate diameter into the channel.
When the pathologically changed tissues are absent beyond the borders of thrombosis, cryo­
destruction is considered as radically complete. In the postoperative period, antiseptic care 
for the cryonecrosis zone is carried out until its rejection.
According to physics studies, the temperature of liquid oxygen is −182°C. The phenomenon 
of ambient oxygen liquefaction on metal objects cooled with liquid nitrogen occurs due to the 
difference between the temperature of liquid nitrogen (−196°C) and the temperature of oxy­
gen liquefaction at normal atmospheric pressure. Physical and chemical experiments dem­
onstrated that the atmospheric fraction liquefied passively with the most chilled instruments 
represents molecular oxygen.
The optimal time for histological sampling was identified by the experimental studies on ani­
mals with grafted skin tumors. It turned out that the minimum period for the emerging first 
signs of localization of the future demarcation line is 6 hours, and this sign is a line of ingres­
sion of solid thromboses in all blood vessels in the tissue. 12 hours is a period when necrotic 
changes do not complicate morphological identification of the tumor after cryoablation.
Moreover, the experiment shows that a clearly established border of the future cryonecrosis 
and tissue rejection at the border of solid thromboses occurs within the specified time period 
only after the most intensive applicative cryodestruction performed with adhesion and against 
the temperature of cryoapplicator, which visualizes the ambient oxygen liquefaction on the 
cryo-instrument. Cryodestruction performed at less values of negative temperatures does not 
provide a clear boundary for the future demarcation line in 6 hours and the cryonecrosis 
border does not coincide with the boundary lines for thromboses and freezing but lies within 
this zone, because cryoablation process at temperatures less than −182°C proves less effective.
The proposed cryosurgical method of treatment ensures the following positive effects:
• radical therapeutic effect for all precancerous diseases of visual localization;
• standardization of the most intensive destructive effect from cryoablation, due to the stabi­
lization of the lowest temperature value for cryoapplicator;
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• visualization of the lowest possible temperature on the cryo-instrument, under ambient 
conditions;
• emergence of a stable, well-defined under visual and histological examinations, change in 
the tissues, which coincides with the line of the future tissue rejection—solid thrombosis 
of small blood vessels that appears in a clearly defined time frame and depends on the 
intensity of cryoablation;
• simultaneously provided morphological verification of the diagnosis of skin tumor to be 
removed and the evaluation of radicality of cryogenic destruction;
• possibility to confirm the completeness of the destructive effect underway within the first 
day after cryoablation and to identify the need for additional cryogenic exposure;
• ensuring the absence of relapses, even in malignant tumors at early stages;
• robust hemostasis during manipulations; and
• histotypic tissue regeneration, without the formation of rough scar.
9. Cryo-circular excision in treatment of skin melanoma
Along with squamous cell and basal cell skin cancers, melanoma refers to the malignant 
tumors and represents one of the most dangerous skin cancers in humans, which is often 
recurrent and metastasizing into almost all organs via lymphatic and hematogenous path­
ways. Its characteristic feature is a weak or even absent response of the body, so melanoma 
often progresses rapidly [4–6].
In the opinion of medical cryology community of Nizhny Novgorod, the major advantages 
of cryosurgery are best manifested in treating the skin melanoma, such as ablastics, due to 
the tissue reactions that develop immediately after freezing (swelling around the focus with 
an increase in the interstitial pressure, lymphostasis, compression, and thrombosis of blood 
vessels), and feasibility of application in hard-to-reach areas of tumor location. Studies con­
ducted by the national and foreign researchers have proved that cryogenic exposure creates 
conditions for rapid fixation of melanoma cells with their subsequent devitalization and thus 
can prevent the dissemination of tumor cells as much as possible [3, 7, 8]. The cryogenic 
method is a choice of priority in treating skin melanomas located in anatomically inaccessible 
places, such as the external ear, angle of eye, nose wing, etc., where traditional surgical inter­
vention is associated with the formation of a cosmetic defect.
Diagnosing melanoma is distinguished by an absolute ban on aspiration, incisional or exci­
sional biopsy. Such intervention gives an impetus to the intensive tumor growth, metastasiz­
ing, and hematogenous dissemination of the process [8–10]. In regard to melanoma, only 
complete removal within the healthy tissue is permissible, with subsequent histological exam­
ination. In all cases of the emerging pigmented skin tumor or rapidly changing pigmented 
formation against the absent clinical signs of cutaneous metastasis, diagnosis and treatment 
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should be started with the cryogenic exposure. During this procedure, a column biopsy is 
taken and a part of pathological tissue is forwarded for complete morphological examina­
tion. Sampling for histological examination should include two tumor fragments—for urgent 
and routine examination. Such approach ensures the absolute ablasticity and high diagnostic 
accuracy, despite the conventional view that cryodestruction of melanoma is not applied, due 
to the impossibility to reliably determine the level of invasion into the underlying tissues [11].
One of the reasons for the unsuccessful radical cryodestruction of malignant tumors is the 
inclination to visually correlate the clearly defined (usually, ultrasonic-aided) freezing zone 
with a hypothetical tumor boundary. However, malignant tumors are distinguished from the 
benign ones by lacking clear boundaries. Variable prediction of tumor infiltrate boundaries 
is possible only at early stages, and they are highly individual for each type of a malignant 
tumor and its localization, which stipulates the urgent search for the boundaries of the latent 
spread of the primary focus of neoplasia. The computerized microdermoscopy systems avail­
able to date improve early melanoma diagnosis from 60 to 90%, but often under experimental 
conditions only. Therefore, if cryodestruction is applied solely with a radical purpose, even 
with localized, externally small malignant tumors, it should be performed within the frame of 
generally accepted rules of surgical radicality.
No less surprising is the faulty trend to issue indications for cryodestruction only after unsuc­
cessful treatment outcomes from all other methods or during relapses. Obviously, combining 
radio- and chemotherapy technologies with cryodestruction are expedient in conditions of 
the disseminated process. Such combination has logic and sense when planning deep freezing 
of the entire neoplasm prior to radiotherapy, regional or systemic chemotherapy, since under 
this condition, cryodestruction brings the effect of potentiation and initially provides ablastic­
ity to the whole treatment schedule.
A string requirement in applying the cryogenic method is the availability of appropriate cryo­
applicators capable of creating complete and irreversible necrosis of the entire volume of 
tumor tissue within the surrounding healthy ones [3].
9.1. Cryo-exposure procedure
The most adequate instrument for deep freezing of the skin melanomas is an applicator with a 
ring-shaped working surface and an open tube mounted on it. The applicator is placed on the 
healthy tissue around the tumor. Cryodestruction is performed with a continuously cooled 
ring-shaped cryoapplicator until the freezing zone expands 1–2 mm beyond its boundaries. 
Deep cooling with adhesion allows for freezing melanoma with simultaneous and all-round 
preblocking of blood supply, which excludes mechanical contact with the tumor. The tube 
accelerates the freezing process, due to the simultaneous direct exposure of the exophytic part 
of the neoplasm to liquid nitrogen. Cryobiopsy is taken via the tube opening without break­
ing contact between the instrument and the frozen tissue.
When the diagnosis of skin melanoma is confirmed by the urgent histological test, cryolaser 
excision of the tumor is performed in a single frozen block. Focused radiation of the CO2 laser is directed along the frozen tissue surrounding the applicator, preferably around −20°C 
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isotherm. Additional cryo-irrigation along the incision line is carried out using “Ledok” appa­
ratus. Such excision may also be performed using ЭХВЧ-500 electrosurgical apparatus (elec­
trocautery). The control biopsy is taken from the sides and the bottom of the resultant wound 
defect, as well as around its circumference, stepping 0.5–2.5 cm from all sides (depending on 
the tumor thickness). The postoperative wound is closed in layers.
Application of this technique in patients with skin melanoma (operated using tumor cryofixa­
tion, cryobiopsy, and cryo-extirpation) can reduce significantly (twofold to threefold) the vol­
ume of surrounding healthy tissues removed during surgery, as compared with the traditional 
surgery. Another advantage of this technique is the fact that preradiation therapy is not required. 
When used properly, this technique demonstrates 100% 5-year survival rate of patients.
If the absence of metastases is confirmed, cryoablation may be applied without removing a 
single block of the frozen pathological tissue, in order to provide the immunostimulatory 
effect by prolonged preservation of the devitalized frozen tumor tissue in contact with the 
body. In such cases, a ring-shaped applicator or “Ledok” cryoapparatus (with nonvacuum 
cannula of 10–12 mm diameter, opened at the working end) are used.
To enhance heat transfer and encapsulation properties, magnetic gel is used in cryo-circular 
excision, applied as a sealing layer to the healthy skin at the site of the expected cryoapplica­
tor placement and a ring-shaped magnet placed at the applicator. Radical cryoablation for 
the skin melanoma is performed in five to seven freeze-thaw cycles depending on the size of 
neoplasia.
When implementing cryoablation with “Ledok” device, a cotton ring impregnated with 
dimexidum 40% solution should be tightly placed around the applicator at the distal part of 
the cannula. This ring provides adhesion and, being passively soaked by the liquefied ambi­
ent oxygen flowing down along the cannula wall, represents an active cryoapplicator continu­
ation when its temperature is stabilized at below −182°C, and surrounds gently the tumor 
tissue of any configuration.
At the first stage, the tumor is frozen up to its visible borders; then the cannula is warmed 
actively and retracted. After that, cryobiopsy is taken via a hole in the frozen cotton ring. 
Urgent morphological confirmation of the melanoma diagnosis qualifies for the extensive 
cryosurgery, upon the same methodology, providing a visible spread of the freezing zone 
beyond the tumor border not less than 1.5 cm in all directions, overlapped freezing zones 
and five to seven freeze-thaw cycles repeated for each point of the visible pathological tissue.
All manifestations of facultative precancerous skin diseases (in particular, all exophytic pig­
mented lesions) are subjected to cryoablation in the same or the next day.
At the stage of clearly marked demarcation line and gradual dehydration of the top cryone­
crosis layer (3–5–7 days after the first cryoablation), cryo-destruction procedure is repeated, 
in order to accelerate mummification of the pathological tissue. It is preceded by the removal 
of exophytic part of cryonecrosis and repeated column cryobiopsy, multiple by the tumor 
radius, 1.0 cm indented from the primary focus to underlying healthy tissues (the first under­
lying fascia) is taken.
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If foci of neoplasia are detected, additional cryodestruction of the tumor bed should be per­
formed by the method of interstitial linear freezing with needle flow applicators or the cryola­
ser destruction is applied.
To evaluate the immunostimulatory therapeutic effect, we have examined the immunological 
status before and after treatment, once in every 2 months during the first year and once in 
every 3 months for 5 years starting from the second year. Humoral and cellular immunity was 
evaluated using monoclonal antibodies CD3, CD16, CD4, CD8, CD4/CD8.
Application of cryosurgical treatment for skin melanoma was accompanied by twofold 
increase of CD4/CD8, as compared with the baseline value; in 6 months, the CD4/CD8 level averaged 1.5 ± 0.2. Thus, the cryosurgical treatment provides an immunostimulating effect, 
while the consolidating effect lasts approximately 48 months, depending on the reactivity of 
the immune system.
It should be particularly noted that the mummified cryonecrosis sites on the skin larger than 
4–5 cm2 require active mechanical removal within 1–1.5 months after cryoablation, otherwise 
the epithelialization process is delayed and the dried cryonecrosis site displays itself as a for­
eign body, thus becoming an activator of the secondary inflammation. Complete rejection of 
the damaged melanoma tissue occurs within 2–3 months.
Filling the defect with local tissues or a displaced skin flap after cryo-circular excision of skin 
melanoma is not required. The retracted scar can remain in the cryoablation zone but it is 
incomparably smaller and has less cosmetic defect than that after traditional surgical exci­
sion of such tumor. Local recurrence is not observed provided that all requirements for this 
technique are met.
Specific features of the cryo-circular excision method for skin melanoma make it advan­
tageous for outpatient practice of oncologists. The outcome of treatment is presented in 
Figure 6.
Figure 6. Superficial spreading melanoma T3a N0 M0 (stage IIA, according to AJCC classification): (a) before cryodes-truction and (b) after cryosurgical treatment.
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10. Cryolipolysis
Cryolipolysis or cryo-liposuction is a method of cold destruction of adipocytes and the elimi­
nation of gynoid lipodystrophy. Current studies are aimed at determining the mechanism of 
cryolipolysis but the scientific evidence is still insufficient. At the meeting of the American 
Society for Laser Medicine and Surgery (ASLMS) in 2012, Dr. Christine C. Dierickx introduced 
the theory that decreasing temperature in the subcutaneous fat causes energy starvation in 
adipocytes, which triggers the process of programmed cell death followed by their excretion 
from the body via the blood and lymph. As the number of fat cells in the hypodermis reduces, 
its thickness declines from 20 to 25% in 2–3 months after the procedure. This explains the fact 
that the first result is obtained in a few weeks.
Today, the principle of cryolipolysis is implemented in CoolSculpting ZELTIQ (USA) equip­
ment. This device is approved for use in the Russian Federation. The procedure can be per­
formed on any part of the body except the face, neck, and décolleté. The main condition of the 
cryolipolysis procedure is the presence of the fat layer 1–2 cm thick. The major advantages of 
the cryolipolysis method are: liposuction performed without punctures and cuts; the absence 
of rehabilitation period; and painless procedure and minimum side effects. The indication for 
the procedure is the local destruction of the excessive fat deposits under obesity of various 
etiologies.
10.1. Cryo-exposure procedure
Before conducting cryolipolysis, the size and thickness of the fat fold is evaluated and an 
appropriate nozzle is selected depending on its thickness. Then, a gel is applied to the desired 
exposure area. A handpiece is placed on the exposure area and the skin fold together with 
subcutaneous fat is sucked into it. A vacuum is created. Cryo-exposure is performed for 
60 minutes. The power and speed of exposure are controlled by the device software. To main­
tain the normal blood circulation in tissues, vibratory massage starts simultaneously with the 
local cooling.
After removing the applicator, the skin hyperemia in the “capture” area can be active and 
passive; its manifestations are terminated after 20–30 minutes. At that time, the patient can 
perceive chills and hypoesthesia of the skin surface subjected to cryolipolysis. These phe­
nomena are terminated spontaneously within 20–30 minutes and they do not require medical 
correction.
Possible complications include persistent manifestations of venous hyperemia and prolonged 
hypoesthesia of the local skin area.
The result can be seen 4 weeks after the procedure. The amount of fat tissue in problem areas 
is reduced by 2–4 cm in volume. The thickness of the fat fold is reduced by 3–5 cm. As a rule, 
three to four treatment sessions of 1 hour each are needed for the maximum effect 3 months 
after conducting cryolipolysis.
Application of Cryogenic Methods in Skin Diseases of Different Etiology
http://dx.doi.org/10.5772/intechopen.70509
61
The most significant disadvantages of this method are: high cost of the procedure; delayed 
result; low efficiency in slack skin; one-step reduction of adipose tissue can be performed 
only for one area of the body; destruction of the excess fat deposits is possible on the localized 
areas only; a wide range of contraindications for cryolipolysis procedure: obesity grade II and 
III; electric cardiac pacemaker in the body; pregnancy and lactation; vascular diseases; blood 
diseases; renal and hepatic failure; diabetes; and Raynaud’s syndrome.
Thus, the advantages of the local cryolipolysis method compare poorly with its disadvantages 
against the wide range of contraindications and a number of significant drawbacks, which 
sharply limit the implementation of this method into wide practice.
11. Treatment for hypertrophic scars
Reparative processes (postsurgery, or after thermal, chemical, or mechanical injury) that take 
place in the skin and develop against disturbed local processes of proliferation and differen­
tiation, with an excessive growth of scar tissue, result in the formation of a keloid or a hyper­
trophic scar.
Hypertrophic scars expand up to 3 mm above the skin surface. The scar growth is initiated 
immediately after healing, which distinguishes it from keloids. The color of hypertrophic 
scars may be of pinkish or reddish shade. A mature hypertrophic scar ceases its growth and 
turns pale within the same time interval as a normotrophic scar. The primary clinical sign of 
keloid scars (or keloids) is their capacity for continuous growth. Regardless of the scar age, 
keloids can be active (proliferating) and inactive (stabilized), with alternating periods of rest 
and of increased growth. An active scar elevating above the level of the skin considerably, 
becomes palpably dense and red with a cyanotic shade. Keloids and hypertrophic scars can 
appear not only from the skin injury but also from the resolution of certain dermatoses. The 
incidence of keloid and hypertrophic scarring, complexity, and duration of their treatment, 
as well as predisposition to relapse determine the urgency of the problem considered in this 
monograph.
Emergence of the posteruptive keloids and hypertrophic scars at the sites of resolved acne is 
not uncommon. A number of authors mention that this cosmetic defect leads to psychoemo­
tional disadaptation of patients manifested by a decreased self-esteem, various psychological, 
and in some cases, psychosomatic disorders. Therefore, elimination of cosmetic defects plays 
an important role in the social and interpersonal adaptation of such patients.
Multiple attempts to find a method for effective scar correction were undertaken throughout 
the twentieth century. The most significant and numerous were the methods concerned with 
the local influence upon the excessive keloid tissue. Thus, the core of the problem lies in the 
frequent scar recurrence after their “successful” elimination at the sites of primary occur­
rence, rather than the lack of methods for their destruction or removal. Despite the extensive 
armamentarium of surgical, radiotherapy, and medication treatment methods, the proportion 
of recurrence remains quite high, since none of the suggested methods suppresses keloid 
growth zones, as evidenced by a number of studies.
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Keloid and hypertrophic scars bear clinical similarities but differ by their morphology and 
pathogenetic mechanisms of development. The major differences relate to the structure of the 
microvasculature, type of collagen that forms connective tissue, cellular composition, and the 
structure of intercellular substance [12].
The presence of immature connective tissue is typical for keloid scars; it is characterized 
by an increased content of hyaluronic acid and collagen type III, both possessing high 
hydrophilic properties. Poorly differentiated (immature) cells, juvenile and atypical giant 
fibroblasts are predominant. “Young” and “old” keloid scars also have morphological dif­
ferences. The structure of a “young” keloid is characterized by the presence of four zones: 
epidermis, subepidermal zone, growth zone, and deep zone. The growth zone represents 
keloid tissue. This is a young connective tissue, where numerous young fibroblasts are 
identified, 92 ± 35 cells in the visual field. The presence of giant forms of fibroblasts is typi­
cal. The deficit of blood capillaries was detected (0–1 capillary in 1–3 visual fields) in the 
“young” keloid tissue. “Old” keloids are characterized by the appearing signs of matura­
tion. The growth zone is partially reduced, fibrosis increases, the number of fibroblasts 
declines and vascularization expands (0–3 capillaries in a single visual field), and the zones 
of dystrophic and necrotic modifications emerge. At the same time, the signs of activity (foci 
of young connective tissue) are present.
Hypertrophic scars have another morphological structure. The zones of epidermis and scar 
tissue are identified there. The number of fibroblasts is less than that in keloid tissue (59 ± 2 in 
the visual field), with the predominance of mature forms. Vascularization in the hypertrophic 
scar tissue is increased (3–5 capillaries in the visual field), which determines the biosynthetic 
activity of mature fibroblasts and the excessive growth of collagen type I.
In this aspect, the cryogenic method of scar treatment is the most advantageous, because the 
mechanism of cryogenic destruction is correlated with the specifics of subsequent reparative 
processes in tissues. The treatment for hypertrophic scars is targeted at microcirculatory ves­
sels of the skin, and for keloids—at both the capillaries and the hydrophilic immature connec­
tive tissue, rich in fibroblasts that are extremely sensitive to ultra-low temperatures.
Thus, the mechanism of local cryo-exposure is justified pathogenetically and includes two 
stages. At the first stage, the cells are destroyed directly through the action of ultra-low tem­
peratures, while at the second, destruction of tissues occurs, due to hemodynamic disturbance.
The morphological study of cryobiopsy samples taken from scar tissue 30 minutes after the 
three-cycle cryo-exposure demonstrated the presence of degenerative changes in all zones, 
including the growth zone. Fibroblasts had necrotic modifications and the blood capillar­
ies were under destruction. The microhemodynamics blockade increases destructive changes 
in the tissue. The study of scar tissue samples collected after cryogenic exposure indicates 
that this method allows to completely destroy the mass of scar tissue (keloid or hypertrophic 
scar). This is evidenced by the destruction of microcirculatory vessels and the total necrosis 
of fibroblasts identified in all areas of the keloid scar and in the hypertrophic scar tissue. In 
3–4 months, a regenerate is formed at the site of the former scar, which has the appearance of 
a normal skin and the structure similar to that of organotypic regenaration.
Application of Cryogenic Methods in Skin Diseases of Different Etiology
http://dx.doi.org/10.5772/intechopen.70509
63
11.1. Cryo-exposure procedure
Prior to performing cryodestruction, we determined the linear dimensions and the projected 
area of the scar, as follows. First, he colorant was applied to the skin surrounding the scar 
deformation using the coloring rod. Then the scaled millimeter paper was imposed on the 
stained surface in such a way that one of the mapping directions coincided with the greatest 
length of the scar. Linear dimensions were determined on the obtained imprint, according to 
the millimeter grid, as the distance between the two most distant points located on the long 
axis of the unstained spot and the length of the perpendicular to this axis corresponding to 
the scar section in the region of its greatest width. In case the scar is not stretched relative to 
the skin surface, its diameter is taken as its linear dimension and the scar area is calculated 
by the formula:
  S = a + b / 2 (1)
where, S is the area of pathologically modified skin site, a is the number of totally unstained 
millimeter squares within the unstained spot, b is the number of partially unstained millime­
ter squares within the unstained spot.
At first glance, this step may seem tedious and useless but actually it has great practical 
importance for the choice of cryodestruction method. Treatment for keloid and hypertrophic 
scars should involve a sufficiently deep cryogenic destruction of pathological tissue and be 
always accompanied by the subsequent formation of multiple vesicles and/or bullae at the 
site of exposure.
When the scar area is up to 20 mm2, cryo-exposure without adhesion is applied by cryoinstru­
ments chilled passively or actively, by smoothing the scar surface and stopping the applicator 
for 2–5 seconds at each site.
When the scar area is 20–35 mm2, a stepwise freezing of the entire scar surface is applied by 
touching it with a drop of atmospheric oxygen passively liquefying on the lateral side of the 
non-thermally insulated cannula and flowing down to the “Ledok” cryoapplicator.
When the scar area is 35–55 mm2, a prolonged exposure is applied, a slow rolling of the cotton 
wool tampon with braided mesh-like surface, chilled in liquid nitrogen, along the scar until a 
stable, visible for 4–5 seconds freezing of the scar tissue occurs.
When the scar area is over 55 mm2, a prolonged cryo-irrigation with liquid nitrogen is applied 
until a stable, visible for 5–10 seconds, icing of the entire scar surface occurs, with two to three 
iterations of freeze-thaw cycle at each site during one procedure.
When scar deformities are extensive, a combination of methods is recommended. In order to 
smooth the surface of atrophic scar, cryotherapy with liquid nitrogen is performed as topical 
applications.
Along with the destruction of hypertrophic and keloid tissues, cryo-exposure aids in restora­
tion of skin sensitivity and elimination of functional disorders caused by pathological scars. 
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In this case, the effect is determined by a direct damage to pathological cells and modified 
microcirculation under the influence of extremely low temperatures.
In conclusion, it needs to be emphasized that four main goals should be pursued in develop­
ing the plan and schedule for keloid and hypertrophic scar treatment: functional rehabilita­
tion of the affected anatomical segment, reduced manifestation of local symptoms, improved 
esthetic appearance and prevention of relapse. The absence of a relapse within 2 years repre­
sents a guarantee of successful treatment.
12. Treatment for acne
Acne is a polymorphic disease and one of the most common skin dermatoses with character­
istic clinical manifestations in the form of non-inflammatory (open and closed comedones) 
and inflammatory (papules, pustules, nodes) elements. The lesions are mainly localized in 
seborrheic zones: face, neck, shoulders, chest, and upper back.
Consensus conference organized in 1990 by the American Academy of Dermatology (AAD) 
discussed the challenges of developing a standardized and reproducible system for acne clas­
sification, with special reference to high polymorphism of lesions, diverse combinations of 
acne elements, variability in the course of the disease, severity and density of inflammatory 
lesions at different localizations in the same patient. In accordance with the AAD recom­
mendations adopted in 1991, grading acne severity is evaluated by the number and nature of 
lesions, distinguishing between the mild, moderate, severe and very severe grades. However, 
the lack of precise quantitative gradation complicates their practical application. According 
to the classification adopted at the 20th World Congress of Dermatology [13], acne disease 
is classified into the mild, moderate and severe grades, where the comedonal and papulo­
pustular (up to 10 elements) forms are referred to as “mild,” papulopustular (more than 10 
papulopustules and up to 5 nodes) and nodular (more than 5 nodes)—to “moderate,” and the 
abscessed and conglobate forms—to “severe” grade.
Despite the large number of dedicated studies, acne still persists as the most common der­
matoses in young people. The most widespread clinical variety is acne vulgaris, which peaks 
at the age of 14–17 years old. This draws special attention to the treatment of this dermatosis 
in adolescents. By quoting Sulzberger [14], “There is probably no other disease that causes 
more mental stress, misunderstanding between children and parents, the greater overall lack 
of self-confidence, as well as a lot of mental suffering, as acne,” we can unhesitatingly agree 
that this statement reflects expressively the problems of relationship between the acne and 
the psyche.
With view of such facts that lesions are localized on the face skin and that the face repre­
sents the major link in interpersonal communication, there is no doubt that acne affects the 
emotional status of any patient. Hautmann and Panconesi [15] refer the acne to the group of 
dermatoses, which trigger somatopsychic resonance due to the actual or perceived esthetic 
discomfort. Both Russian and foreign researchers indicate that skin problems, if accompanied 
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by psychological fixation on the disease, come as a psychotraumatic factor. Thus, acne has a 
negative effect on self-esteem and self-perception of patients, interpersonal interactions, and 
social functions.
These observations demonstrate the formation of such patterns as avoidance behavior, 
social phobias, anxiety, depression, sensitive reactions, hypochondriacal disorders, suicidal 
thoughts and attempts, due to acne. The authors agree unanimously that all mental disorders 
developing against acne cause maladaptation in the social, professional, family life and are 
able of disrupting compliance with the treatment for skin pathology.
The study performed by Volkova and Glazkova [16] involved collection, interpretation, and 
integration of clinical data derived from the patients’ communications and observations of 
specialists. Their findings indicate that the overall prevalence of anxiety-depressive mental 
disorders among outpatients with diagnosed acne amounts to 35.2%, of which anxiety makes 
24.2%, depression—26.2%, and mixed anxiety-depressive disorder—43.74%, respectively. 
Anxiety-depressive disorders reduce greatly the quality of life in patients suffering from 
acne. The linkage between the Dermatology Life Quality Index (DLQI), Assessment of the 
Psychological and Social Effects of Acne (APSEA) and mental disorders reflects the relation­
ship between the skin processes and the development of anxiety and depression. Moreover, 
the objective status of a patient does not necessarily coincide with his/her subjective percep­
tion of this disease. Welp and Gieler [17] confirmed this statement in their experimental study 
by observing patients with a pronounced discrepancy between the objective picture of the 
disease diagnosed by the physician and the subjective severity of mental suffering.
Moreover, as noted by Bosse and Hunecke [18], the subjective severity of suffering is 
affected by such factors as localization and visibility, chronic course and skin changes, gen­
der and age, complaints against personal looks, and self-esteem. The subjective perception 
of ugliness can reduce self-esteem until the paranoid reevaluation the disease’s significance. 
Due to the revaluation of the somatic phenomenon, the person becomes morose, minimizes 
communication with surrounding people and tries to avoid external contacts, up to the 
social isolation. According to Bosse [19], a patient with skin disease is granted only a lim­
ited approved social right to make claims; the author calls it “the hypothesis of non-fas­
tidiousness.” The role of negative evaluation of one’s subjective attractiveness is described 
in a large number of works, which can be summarized vividly by Bosse’s [20] quotation: 
“Pimples on the face – scars on the soul.” Cases of dysmorphophobia are common even with 
the minimal acne lesions.
Resolution of dermatosis is often accompanied by the development of persistent posteruptive 
keloid and/or hypertrophic, atrophic scars, which leads to an uneven skin texture. At the same 
time, postinflammatory pigmentation disorders make common cases with acne. Emergence 
of the secondary persistent dyschromia is observed at the sites where dermatosis elements 
were resolved. Melanin hyperchromia, or local hypopigmentation, in combination with post­
eruptive scars, makes a persistent cosmetic defect. Acne disturbs the esthetic effect of the 
skin and thus has a pronounced effect on the psycho-emotional sphere of the patient and his/
her social adaptation. This determines the urgency of developing new adequate treatment 
modalities for acne to address effectively the healthcare and social problems. Undoubtedly, 
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all the above mentioned factors underline the need for a novel method of treating acne with a 
good cosmetic effect, to ensure the esthetic comfort and recover the psychoemotional health. 
Moreover, treatment should be a short-term and highly effective, in order to avoid psychoso­
cial consequences.
Several important factors are identified in the pathogenesis of acne: hyperplasia and hyper­
function of sebaceous glands, follicular hyperkeratosis, microbial colonization, and inflam­
mation of the sebaceous gland. Inflammation can be both superficial and deep, which brings 
about a variety of clinical manifestations. A vast number of national and international works 
is devoted to studying skin micro-landscape in patients with acne. In 1983, V.M. Kovalev 
studied the microflora of acne elements; 668 strains were isolated and identified, where 
staphylococci communities and St. aureus strains prevailed. This was apparently associated 
with the presence of excoriations in the area of localized pathological elements, which pre­
conditions higher St. aureus incidence under this pathology. Microbial associations were 
found to be inoculated more often than monocultures. To date, it is commonly believed that 
acne is closely associated with the excessive colonization of the skin and its appendages by 
Propionibacterium acnes (R. Acnes), the dominating follicular resident organism. There exist 
other opinions but these are in minority.
Given the key role of pathogenic microorganisms in the pathogenesis of acne, the applied 
treatment modalities become obvious.
Antibiotics have been used for over 40 years until now and they represent a fundamental part 
of modern acne therapy, as confirmed by the recommendations of the International Union 
of Acne Treatments (Paris, 2002). The limiting factor to the topical antibacterial therapy is 
its time length. A lasting positive effect can be achieved only when applied permanently for 
4–6 months, because such medications should exercise their curative effect through several 
periods of the epithelial renewal. Unfortunately, these terms of use involve a high risk of 
developing resistance. According to Kar [21], the first clinically significant changes in P. acnes 
sensitivity were found in the USA in the late 1970s. Later, in the late 1980s- early 1990s, the 
comprehensive studies revealed clinically significant resistance to antibiotics and identified 
strains with multiple antibiotic resistance, as reported by Del Rosso [22]. Moreover, Rivera 
[23] emphasized that resistance was developed not only by the skin surface bacteria but also 
microbial populations in the nasal cavity, which is a permanent reservoir of microflora and 
can reduce the effectiveness of antibiotic therapy. Kirichenko [24] pointed out the fact that 
microorganisms are characterized by natural and acquired resistance to antibiotics; they sur­
vive successfully and retain their virulence, especially in microbial associations. Eady [25] 
emphasized that patients with developed resistance to local forms of antibiotics were also 
unresponsive to systemic antibiotic therapy. Moreover, it should be kept in mind that pro­
longed use of topical broad-spectrum antibiotics can lead to the appearing gram-negative 
rods on the facial skin that are uncharacteristic of its natural microflora and can eventually 
result in the development of gram-negative folliculitis, untreatable by traditional methods.
Despite the available abundance of antibacterial drugs, all those have diverse side effects. We 
will not list in detail the side effects that occur during systemic antibiotic therapy. The most sig­
nificant complications, such as dysbiosis of various localization, hepatotoxicity, hematologic 
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reactions, or toxic epidermal necrolysis are known to every physician since student’s years. 
When appointing a certain drug to the patient, a full list of complications and contraindica­
tions can be viewed in the national medication registry.
Here, we will only mention that many antibacterial preparations included in the standard 
treatment plans cause photosensitization and, therefore, an increased risk of dermatoses 
based on photodynamic reactions. In addition, there is a high risk of medical melanodermia, 
against the prolonged intake of drugs with pigment-forming properties, which presents an 
additional cosmetic problem. Moreover, antibiotic treatment can be considered as a major risk 
factor for scarring, especially in the presence of papules or pustules, since antibiotics trigger 
the intensified scarring processes in the lesions.
Burkhart and Gottwald [26] indicated the need to develop new technologies in acne treatment 
aimed at minimizing the use of antibiotics and thus to prevent the development of micro­
flora resistance. We fully share the opinion stated by Zainullina [27] concerning the modern 
demand for a totally new approach to the effective treatment of various forms of acne.
In 2009, by the decision of the Global Alliance for the Treatment of Acne (GA), retinoids 
were introduced into the list of drugs of the first choice, in addition to topical antibiotics. 
The adverse effects of retinoid therapy include xerophthalmia, conjunctivitis, cheilitis, irrita­
tive dermatitis, skin xerosis, erythema, nasal hemorrhage, pyogenic granuloma, impetigo, 
allopathy, Achilles tenosynovitis, hyperostosis, myalgia and arthralgia, hepatotoxicity, neu­
tropenia, benign increased intracranial pressure. However, the most significant complica­
tion is teratogenicity. According to Racine [28], 50% of pregnant women under isotretinoin 
treatment developed grave intrauterine fetal anomalies in the first trimester of pregnancy 
including pathologies of the cardiovascular system, central nervous system, skeleton and 
sensory organs.
A trend towards increasing resistance of etiologically significant microorganisms to basic 
antibiotics used in the standard treatment regimens determines the urgent imperative to find 
the effective acne treatment. Treatment of various clinical forms of acne is still a challenge, 
despite the already available algorithms and protocols for patient management. Thus, for 
example, the effectiveness of antibiotic therapy depends not only on sensitivity, but also on 
the ability of medications to be delivered to the target organ. Poor skin permeation presents a 
limiting factor for some antibiotics that have proven high sensitivity of pathogenic microflora. 
In addition, it is established that P. acnes secretes glycocalyx biofilms impermeable to antibiot­
ics. For this reason, topical medications are applied mostly as components of fixed dose com­
bination. Recommendations of the European Dermatology Forum (EDF) for the treatment of 
acne (2011) emphasized the fundamental importance of combined therapeutic approach to all 
pathogenetic components in the topical acne treatment, taking into account full diversity of 
pathogenetic factors.
Resistance of various groups of microorganisms to antimicrobial drugs stated in the treatment 
algorithms has been studied extensively since 1979 by Russian and foreign authors. Their find­
ings demonstrated the general long-term trend toward increasing resistance of the main micro­
bial agents of pathogenetic significance to the basic antibiotics. Development of resistant strains 
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and, consequently, reduced effectiveness of antibacterial treatment determine the need for moni­
toring the microflora of skin biota, together by identifying the sensitivity of cause-significant 
groups of microorganisms to antibacterial drugs. There is no possibility to perform antibiotics 
sensitivity tests in routine clinical practice. In this regard, new approaches to the treatment of acne 
are needed, which would prevent the emerging resistance in cause-significant microorganisms.
The complex nature of pathogenesis dictates the need to affect all pathogenic factors of acne, 
particularly for local therapy, as confirmed by the EDF recommendations (published in 2016), 
which reaffirmed the importance of combined therapeutic approach to all pathogenetic com­
ponents in the topical acne treatment.
However, cryotherapy fully meets all these requirements. We have considered the opinion of 
Konchugova [29] and developed a non-drug technology for the treatment of acne. The therapeu­
tic effect is based on the normalized microflora of the facial skin and its appendages, improved 
microcirculation in the foci of dermatosis, eliminated follicular hyperkeratosis, and improved 
sebum evacuation. Local cryo-exposure causes the destruction of differentiated keratinocytes, 
intensifies desquamation of epidermal corneocytes and facilitates exfoliation of the epidermis.
The species composition of microbial community and the antibiotic sensitivity of its dominant 
component can be analyzed endlessly. We have already mentioned the vast amount of rele­
vant studies, which bring only one conclusion – the increasing resistance of microbial associa­
tions to the antibiotics. For this reason, we did not investigate the facial microbial landscape 
with the subsequent determination of antibiotic sensitivity. Sharing the opinion of E. Rivera, 
we studied the antimicrobial effectiveness of cryotherapy on microbial populations in the 
nasal and oral cavities under the ENT pathology. Our findings were published in a number 
of other papers and here we would only notice that there are no microorganisms or microbial 
associations that are insensitive to ultra-low temperatures.
Skin smoothness was evaluated by the computer analysis of facial skin replicas in patients with 
severe late acne after cryogenic treatment and in similar patients after traditional treatment. A 
silicone-based replica reflects all irregularities of the skin microrelief. According to our results, 
it can be stated unequivocally that cryogenic treatment for acne smoothes the skin micro-relief 
considerably, thus improving greatly the esthetic posttreatment effect on the facial skin. Due 
to the labor-intensive process of manufacturing skin replicas, the analysis of images obtained 
directly with high-resolution digital cameras has become very popular in today’s practice.
Evaluation of the immune status in patients with moderate to severe acne prior to treat­
ment demonstrated a decrease in the absolute content of CD3, CD4, CD8, and an increase in 
CD72. A decrease in the relative and absolute content of T suppressors with the CD4 + and 
CD8 + markers, B-lymphocytes with the CD72 + marker was characteristic of the patients 
with papulopustular form. In some cases, a decrease in the absolute content of the total 
T-lymphocytes with a CD3 + marker and T-helpers with the CD4 + marker was found against 
the normal values of the total leukocyte and lymphocyte counts.
The immunomodulating effect of cryo-exposure on parameters of the cellular and humoral 
components of immune system was translated into an increase of conventionally low baseline 
values for the absolute content of lymphocyte subpopulations with CD4+, CD8+, CD72+ markers 
Application of Cryogenic Methods in Skin Diseases of Different Etiology
http://dx.doi.org/10.5772/intechopen.70509
69
and IgA serum content. In patients with low baseline levels, there was a trend towards an 
increase in CD4+, CD8+, CD16+, and a substantial increase in CD72+, IgA and IgG in the blood. 
As regards the humoral component of immune system, IgA and IgG concentrations signifi­
cantly decreased and IgM concentration increased; these parameters were in direct correlation 
with CD 72. IL-1 concentration in the blood of patients with acne increases with the increasing 
disease severity and is increased twice under “severe” grade. These disturbances indicate the 
inhibition of innate and adaptive immunity and the depletion of reserve capacity of the body.
12.1. Cryo-exposure procedure
Our practice of cryogenic treatment for acne relies upon the AAD classification (modified 
Russian version), which enables the most adequate selection of the tentative cryo-exposure 
method:
• Grade I is characterized by the presence of comedones (open and closed) and up to 10 
papules;
• Grade II is characterized by the presence of comedones, papules, and up to 5 pustules;
• Grade III is characterized by the presence of comedones, papulo-pustular rash, and up to 
5 nodes;
• Grade IV is characterized by a pronounced inflammatory reaction in the deep dermal lay­
ers, along with soreness and ulceration, formation of fistulae and nodulocystic elements.
Inverse acne (acne inversa), conglobata-cystic acne (acne conglobate), and resistant acne are 
subjected to cryogenic treatment in line with our method developed for the Grade IV acne 
severity, according to the above classification. To implement these techniques, we use a set 
of instruments for medical cryology developed by Dr. V.I. Kochenov. Prior to the start of 
cryo-exposure, the facial skin is wiped with a cotton tampon moistened with 3% salicylic acid 
alcohol solution and a drop of 10% glycerol solution is applied to each acne element. Given 
the high polymorphism of lesions, diverse combinations of acne elements, and to improve the 
effectiveness of treatment, we apply a combination of cryogenic methods.
Acne severity Grades I and II: cryodestruction of each acne element with cryostick chilled in 
liquid nitrogen. Cryo-exposure is continued until the complete icing of the pathological ele­
ment. Each cryo-manipulation consists of three freeze-thaw cycles. Then, a prolonged cryo-
exposure is performed by rolling a cotton wool tampon with a woven mesh surface, cooled in 
liquid nitrogen, over the entire face skin (and/or other site with signs of dermatosis), until a 
stable, persistent for 4–5 seconds, visible freezing track occurs.
Grade III: cryo-irrigation with liquid nitrogen of each acne-element using a nozzle for inter­
stitial linear freezing, until a stable, visible for 5–10 seconds icing of the entire surface of the 
pathological element occurs, with two to three iterations of the freeze-thaw cycle at each site 
during one procedure.
This is followed by the facial cryomassage (and/or other site with signs of dermatosis), accord­
ing to the technique described above.
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Grade IV: consecutive freezing of pathological acne elements by applying a drop of atmo­
spheric oxygen liquefied passively on a cannula (4 mm), using “Ledok” cryoapparatus with 
an oval pointed applicator. Each acne element is subjected to cryo-exposure three times. Then, 
cryomassage of facial skin (and/or other site with signs of dermatosis) is performed with a 
roller cooled in liquid nitrogen, until a visible white freezing trace is formed.
Our treatment method for provoked acne (acne artificialis, acne mechanica, acne venenata, 
contact acne, acne toxica, acne de la brilliantine, acné excoriée des jeunes filles) and Gram-
negative folliculitis involves topical application using an applicator with the meshed-cellular 
elastic surface, 7–10 cm long, fixed to the handle. The applicator is moistened with liquid 
nitrogen, placed parallel to the treated surface and is slid in continuous rotational move­
ments, under light pressure from the operating hand, over the affected surface until the min­
ute skin whitening is formed.
Cryo-sessions are conducted once or twice per week. Depending on the acne severity, the 
course includes 10–15 procedures.
Cryogenic treatment for acne affects successfully three key components of pathogenetic sig­
nificance through normalizing the sebum evacuation and destroying microbial associations 
and thus it arrests inflammation. At the same time, cryo-exposure triggers a pronounced 
immunomodulatory effect. The clinical effectiveness of cryotherapy is translated into the 
shorter time of treatment, the longer remission period, as well as the prevention of posterup­
tive scarring and persistent dyschromia.
Its high efficiency is based on the marked compensation of the initial microcirculatory distur­
bances and the immunocorrecting effect on both the cellular and humoral immunity, which is 
manifested in the normalized ratio of immunoregulatory subpopulations of T-lymphocytes, 
increasing their functional activity, and recovery of serum immunoglobulins A and G up to 
Figure 7. Facial skin in a female patient with acne disease, severe grade (a) before and (b) after completed treatment 
course.
Application of Cryogenic Methods in Skin Diseases of Different Etiology
http://dx.doi.org/10.5772/intechopen.70509
71
their normal level. Moreover, ultra-low temperatures destroy melanocytes, thereby prevent­
ing traumatic pigmentation and local melanodermy. Additionally, the obtained morphologi­
cal data prove that cryodestruction provides an effective treatment method for posteruptive 
keloids and hypertrophic scars, ensuring their complete destruction and the subsequent 
skin regeneration, similar to that organotypic regeneration. The outcome of treatment is pre­
sented in Figure 7.
13. Conclusion
Dermatoses, in particular, acne and psoriasis, can provoke sensitive reactions and hypochon­
driac disorders. Obviously, formation of secondary (in relation to the somatic pathology) 
mental disorders depends on a number of social and demographic factors, specifics of the 
primary disease, and premorbid properties of the person, but eventually they only emphasize 
the significance of this problem. In addition, the internal picture of the disease, as the major 
complex of secondary psychological symptoms, can complicate the course of the disease in 
certain cases, hinder the success of therapeutic measures, and slow down the rehabilitation. 
Treatment for dermatoses is in need and the effective treatment is in double need. Treatment 
of all dermatological pathologies can not be described just in one chapter and for this rea­
son the priority was given here to the most common dermatoses. Our current work includes 
development of a guideline for physicians “Cryogenic treatment methods in dermatology” 
(the tentative title).
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